India’s First Indigenous MRI Machine Set to Lower Treatment Costs and Boost Self-Reliance
India has successfully developed its first indigenous MRI machine, a major step toward self-reliance in medical technology. The 1.5 Tesla MRI scanner is scheduled for installation at AIIMS Delhi by October for trial runs. This initiative aims to reduce healthcare costs and lessen dependence on imported medical devices, which currently account for 80-85% of the market.
To facilitate this development, AIIMS Delhi has signed a Memorandum of Understanding (MoU) with the Society for Applied Microwave Electronics Engineering and Research (SAMEER), an autonomous R&D laboratory under the Department of Electronics, Government of India. This agreement paves the way for the installation of the first indigenous MRI machine, marking a significant advancement in India’s healthcare sector.
Looking For a Medical Device Regulatory Consultant?
Let’s have a word about your next project
The initiative aligns with the country’s efforts to enhance domestic medical manufacturing, as a substantial percentage of critical care equipment, ICU devices, robotic surgery tools, and MRI scanners are currently imported. By developing indigenous alternatives, India aims to improve accessibility to advanced medical technology while reducing costs.
The Ministry of Electronics and Information Technology (MeitY) has led the development of two critical healthcare technologies—the first indigenous MRI machine and a 6 MEV Linear Accelerator. SAMEER has acted as the implementing agency in collaboration with the Centre for Development of Advanced Computing (C-DAC) in Trivandrum and Kolkata, the Inter University Accelerator Centre (IUAC), and Dayanand Sagar Institute (DSI).
This milestone is expected to revolutionize India’s medical landscape, ensuring high-quality, cost-effective healthcare while reinforcing the vision of Atmanirbhar Bharat (self-reliant India).
Want to Know More In Detail?
Role of Operon Strategist in Regulatory Compliance
Ensuring regulatory approval is key to bringing indigenous medical devices to market. Operon Strategist, a trusted regulatory consultant, assists manufacturers in meeting CE Marking, FDA 510(k), CDSCO, SFDA, and UKCA compliance.
Operon provides facility layout design, cleanroom planning, machine validation, and global regulatory compliance support, ensuring adherence to ISO 13485, FDA QSR, and MDSAP standards. By streamlining approvals, Operon helps manufacturers introduce cost-effective, high-quality medical devices, accelerating India’s journey toward self-reliance in healthcare.
